bioAffinity Technologies, Inc.
BIAF
$2.96
-$0.29-8.92%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.27M | 1.85M | 2.21M | 2.35M | 2.40M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.27M | 1.85M | 2.21M | 2.35M | 2.40M |
| Cost of Revenue | 1.02M | 1.37M | 1.56M | 1.44M | 1.41M |
| Gross Profit | 252.90K | 485.70K | 645.40K | 910.20K | 989.90K |
| SG&A Expenses | 2.21M | 2.45M | 2.92M | 2.36M | 2.47M |
| Depreciation & Amortization | 113.20K | 154.60K | 153.60K | 151.30K | 151.10K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.79M | 4.48M | 5.15M | 4.32M | 4.49M |
| Operating Income | -2.52M | -2.63M | -2.95M | -1.97M | -2.09M |
| Income Before Tax | -4.03M | -2.65M | -2.97M | -2.00M | -2.10M |
| Income Tax Expenses | 29.00K | 8.70K | 0.00 | 2.60K | 5.40K |
| Earnings from Continuing Operations | -4.06M | -2.66M | -2.97M | -2.00M | -2.11M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.06M | -2.66M | -2.97M | -2.00M | -2.11M |
| EBIT | -2.52M | -2.63M | -2.95M | -1.97M | -2.09M |
| EBITDA | -2.31M | -2.57M | -2.79M | -1.82M | -1.84M |
| EPS Basic | -5.07 | -4.91 | -6.02 | -4.84 | -5.56 |
| Normalized Basic EPS | -3.15 | -3.06 | -3.76 | -3.02 | -3.47 |
| EPS Diluted | -5.07 | -4.91 | -6.02 | -4.84 | -5.56 |
| Normalized Diluted EPS | -3.15 | -3.06 | -3.76 | -3.02 | -3.47 |
| Average Basic Shares Outstanding | 800.70K | 541.90K | 492.90K | 413.10K | 379.60K |
| Average Diluted Shares Outstanding | 800.70K | 541.90K | 492.90K | 413.10K | 379.60K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |